Global Pediculosis Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Pediculosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Pediculosis Capitis
1.3.3 Pediculosis Pubis
1.3.4 Pediculosis Corporis
1.4 Market by Application
1.4.1 Global Pediculosis Treatment Market Share by End Users: 2020 VS 2026
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Home Care
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediculosis Treatment Market Perspective (2015-2026)
2.2 Pediculosis Treatment Growth Trends by Regions
2.2.1 Pediculosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediculosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Pediculosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Pediculosis Treatment Industry Dynamic
2.3.1 Pediculosis Treatment Market Trends
2.3.2 Pediculosis Treatment Market Drivers
2.3.3 Pediculosis Treatment Market Challenges
2.3.4 Pediculosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediculosis Treatment Players by Market Size
3.1.1 Global Top Pediculosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Pediculosis Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Pediculosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediculosis Treatment Revenue
3.4 Global Pediculosis Treatment Market Concentration Ratio
3.4.1 Global Pediculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediculosis Treatment Revenue in 2019
3.5 Key Players Pediculosis Treatment Area Served
3.6 Key Players Pediculosis Treatment Product Solution and Service
3.7 Date of Enter into Pediculosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediculosis Treatment Breakdown Data by Type
4.1 Global Pediculosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Pediculosis Treatment Forecasted Market Size by Type (2021-2026)
5 Pediculosis Treatment Breakdown Data by End Users
5.1 Global Pediculosis Treatment Historic Market Size by End Users (2015-2020)
5.2 Global Pediculosis Treatment Forecasted Market Size by End Users (2021-2026)
6 North America
6.1 North America Pediculosis Treatment Market Size (2015-2026)
6.2 North America Pediculosis Treatment Market Size by Type (2015-2020)
6.3 North America Pediculosis Treatment Market Size by End Users (2015-2020)
6.4 North America Pediculosis Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Pediculosis Treatment Market Size (2015-2026)
7.2 Europe Pediculosis Treatment Market Size by Type (2015-2020)
7.3 Europe Pediculosis Treatment Market Size by End Users (2015-2020)
7.4 Europe Pediculosis Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pediculosis Treatment Market Size (2015-2026)
8.2 Asia-Pacific Pediculosis Treatment Market Size by Type (2015-2020)
8.3 Asia-Pacific Pediculosis Treatment Market Size by End Users (2015-2020)
8.4 Asia-Pacific Pediculosis Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Pediculosis Treatment Market Size (2015-2026)
9.2 Latin America Pediculosis Treatment Market Size by Type (2015-2020)
9.3 Latin America Pediculosis Treatment Market Size by End Users (2015-2020)
9.4 Latin America Pediculosis Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediculosis Treatment Market Size (2015-2026)
10.2 Middle East & Africa Pediculosis Treatment Market Size by Type (2015-2020)
10.3 Middle East & Africa Pediculosis Treatment Market Size by Application (2015-2020)
10.4 Middle East & Africa Pediculosis Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 American Vanguard Corporation(TyraTech, Inc.)
11.1.1 American Vanguard Corporation(TyraTech, Inc.) Company Details
11.1.2 American Vanguard Corporation(TyraTech, Inc.) Business Overview
11.1.3 American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Introduction
11.1.4 American Vanguard Corporation(TyraTech, Inc.) Revenue in Pediculosis Treatment Business (2015-2020))
11.1.5 American Vanguard Corporation(TyraTech, Inc.) Recent Development
11.2 Tec Laboratories Inc.
11.2.1 Tec Laboratories Inc. Company Details
11.2.2 Tec Laboratories Inc. Business Overview
11.2.3 Tec Laboratories Inc. Pediculosis Treatment Introduction
11.2.4 Tec Laboratories Inc. Revenue in Pediculosis Treatment Business (2015-2020)
11.2.5 Tec Laboratories Inc. Recent Development
11.3 Arbor Pharmaceuticals LLC
11.3.1 Arbor Pharmaceuticals LLC Company Details
11.3.2 Arbor Pharmaceuticals LLC Business Overview
11.3.3 Arbor Pharmaceuticals LLC Pediculosis Treatment Introduction
11.3.4 Arbor Pharmaceuticals LLC Revenue in Pediculosis Treatment Business (2015-2020)
11.3.5 Arbor Pharmaceuticals LLC Recent Development
11.4 Logic Product Group
11.4.1 Logic Product Group Company Details
11.4.2 Logic Product Group Business Overview
11.4.3 Logic Product Group Pediculosis Treatment Introduction
11.4.4 Logic Product Group Revenue in Pediculosis Treatment Business (2015-2020)
11.4.5 Logic Product Group Recent Development
11.5 The Harvard Drug Group(Major Pharmaceuticals)
11.5.1 The Harvard Drug Group(Major Pharmaceuticals) Company Details
11.5.2 The Harvard Drug Group(Major Pharmaceuticals) Business Overview
11.5.3 The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Introduction
11.5.4 The Harvard Drug Group(Major Pharmaceuticals) Revenue in Pediculosis Treatment Business (2015-2020)
11.5.5 The Harvard Drug Group(Major Pharmaceuticals) Recent Development
11.6 ParaPRO, LLC
11.6.1 ParaPRO, LLC Company Details
11.6.2 ParaPRO, LLC Business Overview
11.6.3 ParaPRO, LLC Pediculosis Treatment Introduction
11.6.4 ParaPRO, LLC Revenue in Pediculosis Treatment Business (2015-2020)
11.6.5 ParaPRO, LLC Recent Development
11.7 Prestige Consumer Healthcare, Inc.
11.7.1 Prestige Consumer Healthcare, Inc. Company Details
11.7.2 Prestige Consumer Healthcare, Inc. Business Overview
11.7.3 Prestige Consumer Healthcare, Inc. Pediculosis Treatment Introduction
11.7.4 Prestige Consumer Healthcare, Inc. Revenue in Pediculosis Treatment Business (2015-2020)
11.7.5 Prestige Consumer Healthcare, Inc. Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Details
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Pediculosis Treatment Introduction
11.8.4 Bayer AG Revenue in Pediculosis Treatment Business (2015-2020)
11.8.5 Bayer AG Recent Development
11.9 STADA Arzneimittel AG(Thornton & Ross)
11.9.1 STADA Arzneimittel AG(Thornton & Ross) Company Details
11.9.2 STADA Arzneimittel AG(Thornton & Ross) Business Overview
11.9.3 STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Introduction
11.9.4 STADA Arzneimittel AG(Thornton & Ross) Revenue in Pediculosis Treatment Business (2015-2020)
11.9.5 STADA Arzneimittel AG(Thornton & Ross) Recent Development
11.10 Lavipharm
11.10.1 Lavipharm Company Details
11.10.2 Lavipharm Business Overview
11.10.3 Lavipharm Pediculosis Treatment Introduction
11.10.4 Lavipharm Revenue in Pediculosis Treatment Business (2015-2020)
11.10.5 Lavipharm Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Pediculosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Pediculosis Capitis
Table 3. Key Players of Pediculosis Pubis
Table 4. Key Players of Pediculosis Corporis
Table 5. Global Pediculosis Treatment Market Size Growth by End Users (US$ Million): 2020 VS 2026
Table 6. Global Pediculosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Pediculosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Pediculosis Treatment Market Share by Regions (2015-2020)
Table 9. Global Pediculosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Pediculosis Treatment Market Share by Regions (2021-2026)
Table 11. Pediculosis Treatment Market Market Trends
Table 12. Pediculosis Treatment Market Drivers
Table 13. Pediculosis Treatment Market Challenges
Table 14. Pediculosis Treatment Market Restraints
Table 15. Global Pediculosis Treatment Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Pediculosis Treatment Market Share by Players (2015-2020)
Table 17. Global Top Pediculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediculosis Treatment as of 2019)
Table 18. Global Pediculosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pediculosis Treatment Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Pediculosis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Pediculosis Treatment Revenue Market Share by Type (2015-2020)
Table 24. Global Pediculosis Treatment Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 25. Global Pediculosis Treatment Market Size Share by End Users (2015-2020) (US$ Million)
Table 26. Global Pediculosis Treatment Revenue Market Share by End Users (2015-2020)
Table 27. Global Pediculosis Treatment Forecasted Market Size by End Users (2021-2026) (US$ Million)
Table 28. North America Pediculosis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Pediculosis Treatment Market Share by Type (2015-2020)
Table 30. North America Pediculosis Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 31. North America Pediculosis Treatment Market Share by End Users (2015-2020)
Table 32. North America Pediculosis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Pediculosis Treatment Market Share by Country (2015-2020)
Table 34. Europe Pediculosis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Pediculosis Treatment Market Share by Type (2015-2020)
Table 36. Europe Pediculosis Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 37. Europe Pediculosis Treatment Market Share by End Users (2015-2020)
Table 38. Europe Pediculosis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Pediculosis Treatment Market Share by Country (2015-2020)
Table 40. Asia-Pacific Pediculosis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 41. Asia-Pacific Pediculosis Treatment Market Share by Type (2015-2020)
Table 42. Asia-Pacific Pediculosis Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 43. Asia-Pacific Pediculosis Treatment Market Share by End Users (2015-2020)
Table 44. Asia-Pacific Pediculosis Treatment Market Size by Region (US$ Million) (2015-2020)
Table 45. Asia-Pacific Pediculosis Treatment Market Share by Region (2015-2020)
Table 46. Latin America Pediculosis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 47. Latin America Pediculosis Treatment Market Share by Type (2015-2020)
Table 48. Latin America Pediculosis Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 49. Latin America Pediculosis Treatment Market Share by End Users (2015-2020)
Table 50. Latin America Pediculosis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 51. Latin America Pediculosis Treatment Market Share by Country (2015-2020)
Table 52. Middle East & Africa Pediculosis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 53. Middle East & Africa Pediculosis Treatment Market Share by Type (2015-2020)
Table 54. Middle East & Africa Pediculosis Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 55. Middle East & Africa Pediculosis Treatment Market Share by End Users (2015-2020)
Table 56. Middle East & Africa Pediculosis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 57. Middle East & Africa Pediculosis Treatment Market Share by Country (2015-2020)
Table 58. American Vanguard Corporation(TyraTech, Inc.) Company Details
Table 59. American Vanguard Corporation(TyraTech, Inc.) Business Overview
Table 60. American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Product
Table 61. American Vanguard Corporation(TyraTech, Inc.) Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 62. American Vanguard Corporation(TyraTech, Inc.) Recent Development
Table 63. Tec Laboratories Inc. Company Details
Table 64. Tec Laboratories Inc. Business Overview
Table 65. Tec Laboratories Inc. Pediculosis Treatment Product
Table 66. Tec Laboratories Inc. Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 67. Tec Laboratories Inc. Recent Development
Table 68. Arbor Pharmaceuticals LLC Company Details
Table 69. Arbor Pharmaceuticals LLC Business Overview
Table 70. Arbor Pharmaceuticals LLC Pediculosis Treatment Product
Table 71. Arbor Pharmaceuticals LLC Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 72. Arbor Pharmaceuticals LLC Recent Development
Table 73. Logic Product Group Company Details
Table 74. Logic Product Group Business Overview
Table 75. Logic Product Group Pediculosis Treatment Product
Table 76. Logic Product Group Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 77. Logic Product Group Recent Development
Table 78. The Harvard Drug Group(Major Pharmaceuticals) Company Details
Table 79. The Harvard Drug Group(Major Pharmaceuticals) Business Overview
Table 80. The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Product
Table 81. The Harvard Drug Group(Major Pharmaceuticals) Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 82. The Harvard Drug Group(Major Pharmaceuticals) Recent Development
Table 83. ParaPRO, LLC Company Details
Table 84. ParaPRO, LLC Business Overview
Table 85. ParaPRO, LLC Pediculosis Treatment Product
Table 86. ParaPRO, LLC Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 87. ParaPRO, LLC Recent Development
Table 88. Prestige Consumer Healthcare, Inc. Company Details
Table 89. Prestige Consumer Healthcare, Inc. Business Overview
Table 90. Prestige Consumer Healthcare, Inc. Pediculosis Treatment Product
Table 91. Prestige Consumer Healthcare, Inc. Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 92. Prestige Consumer Healthcare, Inc. Recent Development
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Pediculosis Treatment Product
Table 95. Bayer AG Company Details
Table 96. Bayer AG Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 97. Bayer AG Recent Development
Table 98. STADA Arzneimittel AG(Thornton & Ross) Company Details
Table 99. STADA Arzneimittel AG(Thornton & Ross) Business Overview
Table 100. STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Product
Table 101. STADA Arzneimittel AG(Thornton & Ross) Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 102. STADA Arzneimittel AG(Thornton & Ross) Recent Development
Table 103. Lavipharm Company Details
Table 104. Lavipharm Business Overview
Table 105. Lavipharm Pediculosis Treatment Product
Table 106. Lavipharm Revenue in Pediculosis Treatment Business (2015-2020) (US$ Million)
Table 107. Lavipharm Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Pediculosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Pediculosis Capitis Features
Figure 3. Pediculosis Pubis Features
Figure 4. Pediculosis Corporis Features
Figure 5. Global Pediculosis Treatment Market Share by End Users: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Home Care Case Studies
Figure 9. Others Case Studies
Figure 10. Pediculosis Treatment Report Years Considered
Figure 11. Global Pediculosis Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Pediculosis Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Pediculosis Treatment Market Share by Regions (2021-2026)
Figure 14. Global Pediculosis Treatment Market Share by Players in 2019
Figure 15. Global Top Pediculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediculosis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Pediculosis Treatment Revenue in 2019
Figure 17. North America Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Pediculosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. American Vanguard Corporation(TyraTech, Inc.) Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 43. Tec Laboratories Inc. Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 44. Arbor Pharmaceuticals LLC Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 45. Logic Product Group Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 46. The Harvard Drug Group(Major Pharmaceuticals) Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 47. ParaPRO, LLC Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 48. Prestige Consumer Healthcare, Inc. Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 49. Bayer AG Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 50. STADA Arzneimittel AG(Thornton & Ross) Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 51. Lavipharm Revenue Growth Rate in Pediculosis Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed